| May 5, 2022 |
NY Court of Appeals Reaffirms Plaintiffs’ Burden to Establish “Sufficient Exposure” to Prove Causation in Toxic Tort Cases |
| December 13, 2021 |
FDA Solicits Input on Regulatory Approach to 3D Printing of Medical Devices at the Point of Care |
| November 30, 2021 |
California and Oklahoma Courts Say Drug Companies Aren't Liable Under a Public Nuisance Theory for the Opioid Epidemic |
| November 24, 2021 |
Infrastructure Investment and Jobs Act Requires Secretary of Transportation to Issue Vehicle Safety Standards and Conduct Studies on Vehicle Safety |
| November 12, 2021 |
Biopharma and Medical Device Trends Investors Should Watch in 2022 |
| November 5, 2021 |
Silence Isn’t Golden: Failure to Report Consumer Product Safety Issues Results in Rare $91 Million Criminal Penalty |
| September 24, 2021 |
10 Ways to Reduce Cyberattack Risks on Internet-Connected Medical Devices |
| April 28, 2021 |
New Bills Seek to Repeal Controversial Provision of Product Safety Act |
| March 26, 2021 |
The Supreme Court Rejects "Causation-Only" Test for Specific Jurisdiction |
| March 24, 2021 |
NHTSA Proposes Rule on Safe Deployment of Self-Driving Vehicles |
| February 9, 2021 |
GAO Calls on FDA to Prepare to Resume Inspections of Drug Manufacturers |
| January 12, 2021 |
Florida’s New Year’s Resolution: A "More Rational, More Fair, and More Consistent" Summary Judgment Standard |
| January 8, 2021 |
Appliance Manufacturers Should Prepare for Increased DOE Enforcement Activity |
| December 21, 2020 |
Transition 2021: Top Transportation Policy Issues Facing the Biden Administration |
| December 7, 2020 |
NHTSA Seeks Guidance on Regulating the Safe Deployment of Self-Driving Vehicles |
| November 5, 2020 |
FDA Postpones DSCSA Provision Enforcement by Three Years |
| October 9, 2020 |
FDA Warning Letter Sends Pointed Message to Industry about EUAs and Compliance |
| October 2, 2020 |
Proposed Legislation Would Expand FDA Authority Over Counterfeit Medical Devices |
| September 3, 2020 |
Maryland Joins "Supermajority" of States Adopting Daubert Standard |
| July 17, 2020 |
FDA Plans to Resume Domestic Facility Inspections |
| July 10, 2020 |
FinCEN Provides Additional Guidance for Financial Institutions on Hemp-Related Businesses |
| June 23, 2020 |
FDA Advises Consumers to Avoid Hand Sanitizers Found to Contain Methanol |
| May 29, 2020 |
Eleventh Circuit Holds that Plaintiff Lacks Standing in Cheerios Glyphosate Lawsuit |
| May 27, 2020 |
HHS Advisory Opinion Clarifies PREP Act Preemption Measures and Protection for Pharmacists |
| May 26, 2020 |
Post COVID-19: FDA Regulatory Considerations for Face Mask and PPE Companies |
| May 15, 2020 |
Re-Thinking Dining in the Age of COVID-19: Follow FDA Best Practices for Re-Opening Retail Food Establishments |
| May 8, 2020 |
FDA Reissues EUA for Non-NIOSH Approved Respirators Manufactured in China |
| May 6, 2020 |
Court Tosses Complaint Against Meatpacker Alleging COVID-19 Related Health and Safety Violations |
| May 5, 2020 |
FDA Tightens the Rules for Antibody (Serology) Test Manufacturers |
| May 1, 2020 |
FDA Reminds Companies Manufacturing Hand Sanitizer of the Importance of Using Denatured Alcohol and Continues to Closely Monitor COVID-19 Claims |
| May 1, 2020 |
FDA Turns to 503A Compounding Facilities to Mitigate COVID-19 Drug Shortages |
| April 21, 2020 |
FDA Issues Final Guidance Aimed at Alleviating COVID-19 Drug Shortages through Outsourcing Facilities |
| April 20, 2020 |
Business Disruption in a Pandemic: Allocating Limited Supply |
| April 17, 2020 |
COVID-19 Class Actions: Refund Disputes Rage Over Membership Fees & Event Tickets |
| April 15, 2020 |
NIOSH-Approved Respiratory Protective Devices Are Now "Covered Countermeasures" Against COVID-19 |
| April 15, 2020 |
Mitigating COVID-19 Related Litigation Risk in the Food Industry: Follow FDA Best Practices |
| April 14, 2020 |
FDA Final Guidance for PPE Shortages at Sterile Compounding Pharmacies not Registered as Outsourcing Facilities |
| April 10, 2020 |
In Response to COVID-19 Pandemic, FDA Temporarily Changes Packaging and Labelling Requirements for Shell Eggs |
| April 8, 2020 |
FDA Recommends Social Distancing in Food Facilities to Prevent the Spread of COVID-19 |
| April 7, 2020 |
Emergency Use Authorization for Ventilators and Related Equipment |
| April 7, 2020 |
FDA Releases New Enforcement Policy for Face Masks and Respirators |
| April 6, 2020 |
The FDA Reverses Course and Authorizes the Importation of Non-NIOSH Approved Respirators Manufactured in China |
| March 31, 2020 |
Businesses Face Price Gouging Concerns Amid COVID-19 Crisis |
| March 30, 2020 |
Section 564 of the Federal Food, Drug, and Cosmetics Act: Emergency Use Authorization |
| March 27, 2020 |
PREP Act Immunity from Liability for COVID-19 Related Medical Equipment |
| March 23, 2020 |
Immunity Protections for Product Manufacturers and Distributors Under the PREP Act |
| March 20, 2020 |
FDA Presses Pause on Domestic and Foreign Inspections for all FDA-Regulated Products Due To COVID-19 Concerns |
| March 19, 2020 |
Agencies, Plaintiffs Target Ethylene Oxide |
| March 19, 2020 |
NHTSA Announces Historic Proposal to Modernize Vehicle Safety Standards |
| March 17, 2020 |
Does Bristol-Myers Squibb Apply to Nationwide Class Actions in Federal Court? The First Two Federal Circuits Weigh In |
| March 5, 2020 |
The Fifth Circuit Creates Minimum Approximate Physical Presence Test for General Jurisdiction |
| February 19, 2020 |
Shifting Liability: AI in Medical Devices |
| February 12, 2020 |
FDA Enforcement Trends: Reflecting on 2019 and Looking Onward to 2020 |
| February 4, 2020 |
CBD False Advertising Claims Stayed Pending Further FDA Guidance |
| February 3, 2020 |
It’s Déjà Vu All Over Again: Supreme Court To Revisit the Scope of Specific Jurisdiction |
| January 29, 2020 |
OEHHA Clarifies Responsibilities and the Meaning of "Actual Knowledge" Under Prop 65 Regulations |
| January 16, 2020 |
FDA Enforcement Trends: Reflecting on 2019 and Looking Onward to 2020 |